Ebola, Big Data, Childhood Cancers and Medicines Safety Feature in New IMI Call

Innovative Medicines InitiativeThe Innovative Medicines Initiative (IMI) has launched two Calls for proposals that will advance medicines development in critical areas such as Ebola, childhood cancers, neurological disorders, and eye disease. The Calls will also add to IMI's growing programme on Big Data for Better Outcomes.

Ebola - The recent Ebola outbreak in western Africa infected over 28 000 people and killed over 11 000, starkly highlighting the urgent need for new vaccines, treatments and diagnostic tests for this devastating disease. IMI and others responded to this emergency by rapidly launching Ebola research programmes. However, further efforts are needed to ensure the world is equipped to stop future outbreaks in their tracks. With this in mind, IMI is launching a €70 million open Call for proposals that invites consortia to submit proposals covering diverse aspects of Ebola research, including the development of vaccines, diagnostic tests, and treatments. The resulting projects should be able to capture emerging scientific advances and turn them into healthcare interventions that will increase our readiness to react to future outbreaks of Ebola or related diseases.

In parallel, IMI is launching a standard Call for proposals with seven topics, including two on big data.

Big data for better outcomes - In addition to a topic to coordinate and support the entire big data programme, the Call includes a topic that aims to improve clinical outcomes for people with heart disease through better access to, and use of data.

Childhood cancers - Today, 20% of childhood cancers remain incurable and survivors of childhood cancers often experience long-term side effects. This topic will deliver a platform of research tools to facilitate the identification of potential drugs for childhood cancers.

Alzheimer's and Parkinson's diseases - The focus of this topic is on how protein tangles, which are hallmarks of both diseases, spread throughout the brain. The project results will therefore increase our chance of identifying new targets for drugs.

Chronic pain - Neuropathic pain affects 6-8% of the population and is extremely hard to treat. This topic focuses on improving our understanding of the underlying causes of neuropathic pain, something that will aid in the development of new treatments.

Eye diseases - There are currently no effective treatments for dry age-related macular degeneration (AMD), and it is one of the leading causes of blindness worldwide. This topic aims to develop new and better measures of patients' disease status that could be used when testing new drugs in clinical trials.

Medicines safety - This topic aims to advance the use of imaging in assessments of medicines safety. Among other things, this would improve medicines safety, add to our understanding of why medicines sometimes cause toxicity, and reduce the use of animals in research.

Pierre Meulien, IMI Executive Director commented: "These Calls for proposals demonstrate the added value of IMI. Excellent science exists in all of these research areas, but only by bringing together experts from industry, academia, small biotechs, patient groups, and others can we hope to translate world-class science into improved health for patients."

The Ebola Call (IMI 2 - Call 8) has a total budget of €70 million from IMI that will be available from the first cut-off date of the two year open application period. The other Call (IMI 2 - Call 7) has a budget from IMI of €46.8 million; this will go to eligible universities, small companies, and patient organisations, etc. This will be matched by €46.8 million from the EFPIA companies in the projects; these companies do not receive any money from IMI but contribute largely 'in kind', e.g. by donating their researchers' time, or access to equipment and resources.

IMI 2 - Call 7
Topics on safety, Alzheimer's/Parkinson's diseases, pain, eye diseases, childhood cancers, big data
Deadline for submitting proposals: 17 March 2016
Call documents and details of how to apply: http://www.imi.europa.eu/content/stage-1-18

IMI 2 - Call 8
Ebola and related diseases This Call for proposals will remain open for two years with the following cut-off dates for the submission of proposals: 16 March 2016, 15 September 2016, 16 March 2017, 14 September 2017, 15 March 2018.
Call documents and details of how to apply: http://www.imi.europa.eu/content/imi-2-call-8

About the Innovative Medicines Initiative
The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. It does this by facilitating collaboration between the key players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators.

IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). Through the IMI 2 programme, IMI has a budget of €3.3 billion for the period 2014-2024. Half of this comes from the EU's research and innovation programme, Horizon 2020. The other half comes from large companies, mostly from the pharmaceutical sector; these do not receive any EU funding, but contribute to the projects 'in kind', for example by donating their researchers' time or providing access to research facilities or resources.

Most Popular Now

Interactive Health Apps May Inspire Heal…

Just like real doctors and nurses, online health tools with good - but controlled - communication skills can promote healthier lifestyles, according to researchers. However, if their tone is conversational...

Read more

Augmented Reality Visor to Dramatically …

Employing new photonics technology, European scientists are developing a new Augmented Reality surgical visor in a bid to improve accuracy of interventions, showing anaesthetic and medical data while superimposing a...

Read more

Call for Papers: EHB 2017 - IEEE Interna…

22 - 24 June 2017, Sinaia, Romania. The 6-th edition of the International Conference on e-Health and Bioengineering, EHB 2017, will take place in the city of Sinaia, Romania. This year...

Read more

UK and Italian Health Tech Firms to Help…

Data sharing ambitions set out in newly published sustainability and transformation plans (STPs) have been given a boost by a new strategic partnership between data management specialist Stalis and Italy's...

Read more

From Health Apps to Nursing Robots - A G…

25 - 27 April 2017, Berlin, Germany. Around the world the subject of e-Health is steadily gaining in importance, whether it involves electronic patient files, online video consultations or any of...

Read more

Philips Teams Up with German Startup One…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a partnership agreement with German digital health company Onelife Health to jointly develop innovative connected health...

Read more

EU eHealth Competition 2017

The eHealth Competition is an initiative that rewards the best eHealth / mHealth solutions produced by European SMEs (Small and Medium Enterprises). Its objective is to support business success of...

Read more

Philips and LabPON Plan to Create World…

Royal Philips (NYSE: PHG, AEX: PHIA) and LabPON, the first clinical laboratory to transition to 100% histopathology digital diagnosis, have announced its plans to create a digital database of massive...

Read more

Startupbootcamp Digital Health Berlin: C…

Startupbootcamp Digital Health Berlin supports innovative startups that combine medical knowledge with smart technologies, with special focus on behavior change, diagnostics and genomics, big data and analytics. Startupbootcamp provides mentorship...

Read more

Virtual Reality Cognitive Training Game …

Greek researchers demonstrated the potential of a self-administered virtual supermarket cognitive training game for remotely detecting mild cognitive impairment (MCI), without the need for an examiner, among a sample of...

Read more

Technology Boost for Health and Social C…

Health and social care organisations aiming to be fully compliant with the government’s Personalised Health and Care 2020 plan, can now access electronic health record (EHR) and healthcare integration technologies...

Read more

Philips Introduces Advanced Radiology So…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has unveiled new advanced radiology solutions at the 2017 European Congress of Radiology (ECR). In response to today's...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined